Research summary, original research, 2012

Patient radiation doses in interventional cardiology in the U.S.: advisory data sets and possible initial values for U.S. reference levels

Miller DL, Hilohi CM, Spelic DC. Medical physics. 2012

Read the original paper

In plain language

In a 2008 to 2009 national survey of 171 U.S. cardiac catheterization facilities, patient kerma-area product was higher than in Europe despite similar fluoroscopy times. The authors suggest initial reference levels and conclude patient dose is not optimized.

At a glance

Type of study
Original research, Cross-sectional survey
Who was studied
Patients
Size
n = 171 facilities
Where
United States
Summary based on
the abstract

What it found

  • Possible preliminary U.S. reference levels for diagnostic catheterization and percutaneous coronary intervention (PCI) were proposed from the 75th percentile of national dose distributions.

    Key figures: 75th percentile

  • Fluoroscopy times in the U.S. matched European studies, but kerma-area product was higher in the U.S.

  • The authors conclude patient dose in these procedures is not optimized in U.S. practice.

  • Data came from the 2008 to 2009 NEXT survey covering 171 facilities in 30 states.

    Key figures: 171 facilities in 30 states

Limits to keep in mind

The abstract gives no numeric dose values, and the data come from a facility survey of patient dose metrics. Staff dose was not measured.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.